AXA Framlington Biotech Fund Z INCRegister to Unlock Ratings |
Growth Of 1000 (GBP) | 30/06/2024 |
|
Annual Returns (GBP) | 30/06/2024 | |||||||
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 30/06 | |
Price Return | 9.64 | -6.41 | 19.37 | 32.70 | 3.40 | 3.76 | 1.84 | 7.18 |
+/- Category | -0.65 | 1.55 | -0.82 | 6.74 | 12.43 | 11.60 | 3.12 | 7.73 |
+/- Category Index | -5.55 | -4.56 | 2.66 | -0.23 | 3.10 | 1.30 | -5.49 | -10.69 |
% Rank in Category | 62 | 50 | 58 | 19 | 7 | 23 | 29 | 16 |
Trailing Returns (GBP) | 15/07/2024 | ||
Total Returns | +/- Category | +/- Category Index | |
1 Day | 0.61 | -1.25 | 0.90 |
1 Week | 5.20 | -0.84 | 4.21 |
1 Month | 5.65 | 1.77 | 3.75 |
3 Months | 10.90 | 9.84 | -0.66 |
6 Months | 9.48 | 7.68 | -6.67 |
YTD | 11.02 | 8.92 | -6.90 |
1 Year | 21.31 | 10.80 | -15.04 |
3 Years Annualised | 7.00 | 11.03 | -1.53 |
5 Years Annualised | 10.71 | 3.38 | -2.17 |
10 Years Annualised* | 10.86 | 1.04 | -1.18 |
Category: Sector Equity Biotechnology | |||
Category Index: Morningstar Gbl Biotechnology NR USD |
Quarterly Returns (GBP) | 30/06/2024 | |||
Quarter 1 | Quarter 2 | Quarter 3 | Quarter 4 | |
2024 | 4.52 | 2.54 | - | - |
2023 | -3.97 | -1.08 | 0.18 | 7.02 |
2022 | -8.72 | -0.07 | 15.91 | -1.86 |
2021 | -6.24 | 8.04 | 5.37 | -3.13 |
2020 | 0.33 | 29.25 | -2.28 | 4.72 |
2019 | 16.14 | 0.00 | -9.01 | 12.96 |
|
Advertisement |